[EN] MACROMOLECULES OF DENDRIMER-PLATINUM CONJUGATES<br/>[FR] MACROMOLÉCULES DE CONJUGUÉS DENDRIMÈRE-PLATINE
申请人:STARPHARMA PTY LTD
公开号:WO2015035446A1
公开(公告)日:2015-03-19
The present invention relates to a macromolecule comprising a dendrimer having surface amino groups to which at least one platinum-containing moiety is attached. In particular embodiments, the macromolecule has a plurality of platinum-containing moieties attached to the surface amino groups. In another particular embodiment, the macromolecule comprises a dendrimer having surface amino groups to which at least two different moieties are attached, a first moiety being a platinum-containing moiety and the second moiety being a pharmacokinetic modifying agent or targeting agent. Pharmaceutical compositions comprising the macromolecules and uses of the macromolecules for treating or suppressing the growth of a cancer is also described.
[EN] INSULIN RECEPTOR PARTIAL AGONISTS<br/>[FR] AGONISTES PARTIELS DU RÉCEPTEUR DE L'INSULINE
申请人:MERCK SHARP & DOHME
公开号:WO2017205309A1
公开(公告)日:2017-11-30
Insulin dimers and insulin analog dimers that act as partial agonists at the insulin receptor are disclosed.
本发明揭示了作为胰岛素受体部分激动剂的胰岛素二聚体和胰岛素类似物二聚体。
MACROMOLECULES OF DENDRIMER-PLATINUM CONJUGATES
申请人:STARPHARMA PTY LTD.
公开号:US20160220689A1
公开(公告)日:2016-08-04
A macromolecule comprising a dendrimer having surface amino groups to which at least one platinum-containing moiety is attached is provided. The macromolecule may have a plurality of platinum-containing moieties attached to the surface amino groups. Alternatively, the macromolecule may comprise a dendrimer having surface amino groups to which at least two different moieties are attached, a first moiety being a platinum-containing moiety and the second moiety being a pharmacokinetic modifying agent or targeting agent. Pharmaceutical compositions comprising the macromolecules and uses of the macromolecules for treating or suppressing the growth of a cancer is also described.